The global idiopathic pulmonary fibrosis market size was valued at USD 4.54 billion in 2024 and is projected to reach from ...

The global Cystic Fibrosis Market is valued at $10.4 billion in 2023 and is projected to reach $55.4 billion by 2032, reflecting a Compound Annual Growth Rate (CAGR) of 21.6% from 2024 to 2032. Cystic ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic ...

(MENAFN- EIN Presswire) DelveInsight's Expert market Assessment – A data-driven exploration of Idiopathic Pulmonary Fibrosis epidemiology and commercial potential across the 7MM. LAS VEGAS , NV ...

DelveInsight's Idiopathic Pulmonary Fibrosis Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES, February 13, 2025 ...

The company's IPO follows a $182m Series C funding round last year.

The Cystic Fibrosis Therapeutics Market Research Report for 2025 delivers a comprehensive analysis of the industry's progress, examining both historical trends and the current market landscape. It ...

The global liver fibrosis treatment market is poised for substantial growth, with revenue projections increasing from USD 17.51 billion in 2024 to USD 51.16 billion by 2033. This expansion represents ...

"Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this ...